6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Classical Complement Pathway Mediates Microglia-Dependent Remodeling of Spinal Motor Circuits during Development and in SMA

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          Movement is an essential behavior requiring the assembly and refinement of spinal motor circuits. However, the mechanisms responsible for circuit refinement and synapse maintenance are poorly understood. Similarly, the molecular mechanisms by which gene mutations cause dysfunction and elimination of synapses in neurodegenerative diseases that occur during development are unknown. Here, we demonstrate that the complement protein C1q is required for the refinement of sensory-motor circuits during normal development, as well as for synaptic dysfunction and elimination in spinal muscular atrophy (SMA). C1q tags vulnerable SMA synapses, which triggers activation of the classical complement pathway leading to microglia-mediated elimination. Pharmacological inhibition of C1q or depletion of microglia rescues the number and function of synapses, conferring significant behavioral benefit in SMA mice. Thus, the classical complement pathway plays critical roles in the refinement of developing motor circuits, while its aberrant activation contributes to motor neuron disease.

          In Brief

          Vukojicic et al. show that complement protein C1q is required for the refinement of spinal sensory-motor circuits during normal development, as well as for synaptic elimination in spinal muscular atrophy (SMA). Pharmacological inhibition of C1q or depletion of microglia rescues vulnerable synapses, yielding significant behavioral benefit in SMA mice.

          Graphical Abstract

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Decoding the organization of spinal circuits that control locomotion.

          Ole Kiehn (2016)
          Unravelling the functional operation of neuronal networks and linking cellular activity to specific behavioural outcomes are among the biggest challenges in neuroscience. In this broad field of research, substantial progress has been made in studies of the spinal networks that control locomotion. Through united efforts using electrophysiological and molecular genetic network approaches and behavioural studies in phylogenetically diverse experimental models, the organization of locomotor networks has begun to be decoded. The emergent themes from this research are that the locomotor networks have a modular organization with distinct transmitter and molecular codes and that their organization is reconfigured with changes to the speed of locomotion or changes in gait.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Microglia: Dynamic Mediators of Synapse Development and Plasticity.

            Neuronal communication underlies all brain activity and the genesis of complex behavior. Emerging research has revealed an unexpected role for immune molecules in the development and plasticity of neuronal synapses. Moreover microglia, the resident immune cells of the brain, express and secrete immune-related signaling molecules that alter synaptic transmission and plasticity in the absence of inflammation. When inflammation does occur, microglia modify synaptic connections and synaptic plasticity required for learning and memory. Here we review recent findings demonstrating how the dynamic interactions between neurons and microglia shape the circuitry of the nervous system in the healthy brain and how altered neuron-microglia signaling could contribute to disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.

              The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa-/-) mice were generated by gene targeting and monitored for eight months. C1qa-/- mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.
                Bookmark

                Author and article information

                Journal
                101573691
                39703
                Cell Rep
                Cell Rep
                Cell reports
                2211-1247
                5 December 2019
                03 December 2019
                30 December 2019
                : 29
                : 10
                : 3087-3100.e7
                Affiliations
                [1 ]Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA
                [2 ]Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA
                [3 ]Department of Neurology, Columbia University, New York, NY 10032, USA
                [4 ]Annexon Biosciences, 180 Kimball Way, South San Francisco, CA 94080, USA
                [5 ]Department of Neurobiology, Stanford University, Palo Alto, CA, USA
                [6 ]Lead Contact
                Author notes

                AUTHOR CONTRIBUTIONS

                G.Z.M. conceived the project. A.V. and G.Z.M. designed all of the experiments. A.V. performed the immunohistochemistry assays and image analysis, motor neuron counts, qRT-PCR, genotyping, FISH, western blot experiments, ELISA, in vivo behavior treatments and analysis, motor neuron retrograde labeling, synaptic analysis, and NMJ experiments. N.D. performed all of the physiological experiments and data analysis. E.V.F. participated in the immunohistochemical experiments and analysis. J.G.P. participated in the genotyping and performed the in vivo tracing experiments. T.A.Y. and S.S. provided the anti-C1q and isotype control antibodies produced by Annexon Biosciences and reagents for the ELISA assay. B.A.B. contributed reagents, protocols, and advice on the data analysis. G.Z.M. wrote the manuscript with input from all of the authors.

                [* ]Correspondence: gzmentis@ 123456columbia.edu
                Article
                NIHMS1545831
                10.1016/j.celrep.2019.11.013
                6937140
                31801075
                0d8f1347-c029-42fa-b9ac-f1685ca602fb

                This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Article

                Cell biology
                Cell biology

                Comments

                Comment on this article